Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nektar Therapeutics
Biotech
Nektar CEO slams Lilly's 'egregious error,' laments lost time
Nektar CEO Howard Robin is not backing down after the biotech accused Lilly of botching the math behind the formerly partnered asset rezpeg.
Gabrielle Masson
Aug 8, 2023 8:18pm
Nektar accuses Lilly of botching eczema clinical trial analysis
Aug 7, 2023 8:30am
Lilly hands rights to immunology med back to Nektar
Apr 27, 2023 9:14am
Nektar sticks with immunology, lays off 60% of SF workforce
Apr 18, 2023 7:00am
Lilly, Nektar stop lupus R&D, reassess eczema after phase 2 fail
Feb 24, 2023 6:52am
Nektar pins comeback hopes on Lilly collab and cancer combinator
Jan 11, 2023 5:18pm
